Clinical Trial Update: Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of pembrolizumab plus chemotherapy in patients with various advanced cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Sarcoma
• Small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Advanced Cancer, Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED